title: Performance of adjunctive therapy in bacterial meningitis depends on circumstances.
authors.affiliation: From the *University of Helsinki, and Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland; and †Institute for Infectious Diseases, University of Bern, and Biology Division, Spiez Laboratory, Spiez, Switzerland.
authors.forename: Heikki
authors.initials: H
authors.lastname: Peltola
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Leib
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D017576:Daptomycin / Q000627:therapeutic use; D003906:Developing Countries; D003907:Dexamethasone / Q000627:therapeutic use; D005990:Glycerol / Q000627:therapeutic use; D006801:Humans; D016920:Meningitis, Bacterial / Q000150:complications / Q000188:drug therapy* / Q000191:economics
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D003907:Dexamethasone; D017576:Daptomycin; D005990:Glycerol